Back to LLY
BENDER ROBERT & ASSOCIATES → LLY
BENDER ROBERT & ASSOCIATES LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$20.4M
Q3 2026
Peak value
$21.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13.9M |
| Q4 2025 | $19.3M |
| Q1 2026 | $16.1M |
| Q2 2026 | $21.2M |
| Q3 2026 | $20.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $20.4M | 17.6K | — | — |
| Q2 2026 | $21.2M | 17.6K | — | — |
| Q1 2026 | $16.1M | 17.6K | — | — |
| Q4 2025 | $19.3M | 17.9K | — | — |
| Q3 2025 | $13.9M | 18.2K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B